News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health Perspectives
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Subscribe
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pain
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
MHE State of the Industry survey|
ASH 2025|
AMCP Nexus 2025|
2025 Fall Clinical Dermatology|
ASRS 2025
Advertisement

Kuldeep Singh Rajput

Advertisement

Articles by Kuldeep Singh Rajput

AI

Five Ways Pharma is Leveraging Digital Therapeutics to Demonstrate Value to Health Plans

ByKuldeep Singh Rajput
January 10th 2020

Data from clinical-grade wearables and AI-powered analytics are enabling the transition from ‘pay-per-pill’ to pay-for-value.

Advertisement

Latest Updated Articles

  • AI
    Five Ways Pharma is Leveraging Digital Therapeutics to Demonstrate Value to Health Plans

    Published: January 10th 2020 | Updated:



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

The FDA proposes ditching comparative efficacy studies for biosimilars

2

How new psoriasis, alopecia and atopic dermatitis therapies stood out at Fall Clinical Derm 2025

3

MHE Week in Review – ACA changes worry health system leaders, Flu season may be severe and More

4

Misdiagnosis of Type 1 diabetes remains a major problem, despite advances

5

Higher serotonin levels are associated with schizophrenia in general and negative symptoms specifically, a neuroimaging study finds

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us